483
Wuhan Biocause Pharmaceutical Development Co., Ltd.Wuhan Biocause Pharmaceutical Development Co., Ltd. – FDA 483, Aug 24, 2018
Record Details
Wuhan Biocause Pharmaceutical Development Co., Ltd. in Wuhan, China, was inspected from August 20-24, 2018. The inspection revealed a significant issue regarding the improper storage of USP reference standards, which were not kept under recommended refrigerated conditions. This raises concerns about the suitability of these standards for use in qualifying working standards.
- Inspection date
- August 24, 2018
- Product type
- drugs
View Company Profile
ID · 00961f58-1938-46fe-8a7e-658b59b98e37
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.